Home / Non‐Biological Complex Drugs
Non‐Biological Complex Drugs
News
FDA approves 40 mg follow-on version of glatiramer acetate
posted 09/03/2018
Sandoz, the generics division of Novartis, announced on 13 February 2018 the approval of its 40 mg follow-on version of... |
Research
Biosimilars and follow-on NBCDs for MS in Europe, the US and Canada
posted 19/01/2018
The advent of biological medicines has significantly transformed the landscapes of many disease spaces and improved the lives... |
Guidelines
US guidelines for follow-on NBCDs
posted 01/06/2018
Last update: 1 June 2018The regulatory body for approval of medicines in the US is the Food and Drug Administration (FDA). |
Polices & Legislation
FDA to set up abbreviated pathway for complex products
posted 21/10/2016
As part of the Generic Drug User Fee Amendments (GDUFA II) reauthorization recently agreed with industry [1], the US Food and... |
Reports
Equivalence of complex drug products
posted 21/04/2017
Complex drug products and their generic (or follow-on) versions was the subject discussed at the New York Academy of Sciences... |
Sign up today to receive weekly news on the latest developments in generic and biosimilar medicines!
Generics News Research General
- Generics applications under review by EMA – Jan...Generics/General | Posted 22/01/2021
- Perspectives of prescribing practices in public...Generics/Research | Posted 15/01/2021
- A European pharmaceutical strategy promoting ge...Generics/General | Posted 08/01/2021
- Familiarity with substitution of prescription g...Generics/Research | Posted 11/12/2020
Biosimilars News Research General
- Samsung biosimilars: denosumab clinical trials...Biosimilars/General | Posted 22/01/2021
- Biosimilars of filgrastimBiosimilars/General | Posted 20/03/2015
- EMA recommends approval of adalimumab and insul...Biosimilars/News | Posted 22/01/2021
- Biosimilars and lack of resourcesBiosimilars/Research | Posted 22/01/2021